These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1932372)
1. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines. Jia SF; Kleinerman ES Lymphokine Cytokine Res; 1991 Aug; 10(4):281-4. PubMed ID: 1932372 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
3. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha. Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines. Totpal K; Aggarwal BB Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157 [TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Hori K; Mihich E; Ehrke MJ Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674 [TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma. Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo. Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482 [TBL] [Abstract][Full Text] [Related]
11. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. Beresini MH; Lempert MJ; Epstein LB J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746 [TBL] [Abstract][Full Text] [Related]
12. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Pak AS; Ip G; Wright MA; Young MR Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines. Schiller JH; Bittner G; Storer B; Willson JK Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. Chung IY; Benveniste EN J Immunol; 1990 Apr; 144(8):2999-3007. PubMed ID: 2109008 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2. Ostensen ME; Thiele DL; Lipsky PE J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514 [TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system. Beresini MH; Sugarman BJ; Shepard HM; Epstein LB Electrophoresis; 1990 Mar; 11(3):232-41. PubMed ID: 2111772 [TBL] [Abstract][Full Text] [Related]
17. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. Marfaing-Koka A; Devergne O; Gorgone G; Portier A; Schall TJ; Galanaud P; Emilie D J Immunol; 1995 Feb; 154(4):1870-8. PubMed ID: 7530744 [TBL] [Abstract][Full Text] [Related]
19. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]